Clinical Trials Browser

Phase 1 × INDUSTRY × Radiotherapy × Clear all

Glioblastoma

Carcinoma, Non-Small-Cell Lung

Locally Advanced Rectal Cancer (LARC)

Brain Neoplasms, Glioblastoma, Inhibition, Psychological, Meningeal Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Advanced Tumors

Glioblastoma, Glioma

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Pancreatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

Carcinoma, Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Brain Neoplasms, Glioblastoma

Advanced Solid Tumors

Glioblastoma

Uterine Cervical Neoplasms, Camurati-Engelmann Syndrome

Glioblastoma

Carcinoma, Non-Small-Cell Lung

Bone Neoplasms, Neoplasm Metastasis, Pain

Brain Neoplasms, Glioblastoma, Glioma

Glioblastoma

Glioblastoma

Head and Neck Neoplasms

Carcinoma, Renal Cell

Carcinoma, Non-Small-Cell Lung

Leukemia, Lymphoma, Mucositis, Neoplasms, Plasma Cell

Astrocytoma, Glioblastoma, Gliosarcoma

Prostatic Neoplasms

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Glioblastoma

Clinical Trials

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

FORTRESS

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Phase I Study of RiMO-301 With Radiation in Advanced Tumors

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Study of Avelumab-M3814 Combinations

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

AN0025 and Chemoradiotherapy Combination in Esophageal Cancer

Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

BM201-1001

FLAG

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients

Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer

Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform

Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma

Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer

Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer

Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer

Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support

Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma

A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme